A proposal for a serology-based approach to membranous nephropathy, J Am Soc Nephrol, vol.28, pp.421-430, 2017. ,
Primary membranous nephropathy, Clin J Am Soc Nephrol, vol.12, pp.983-997, 2017. ,
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy, N Engl J Med, vol.361, pp.11-21, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00417718
Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy, N Engl J Med, vol.371, pp.2277-2287, 2014. ,
Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy, J Clin Invest, vol.126, pp.2519-2532, 2016. ,
Pathophysiological advances in membranous nephropathy: Time for a shift in patient's care, Lancet, vol.385, 1983. ,
Pathogenesis of membranous nephropathy: Recent advances and future challenges, Nat Rev Nephrol, vol.8, pp.203-213, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00919135
A statistical model for identifying proteins by tandem mass spectrometry, Anal Chem, vol.75, pp.4646-4658, 2003. ,
Mass spectrometry based proteomics in the diagnosis of kidney disease, Curr Opin Nephrol Hypertens, vol.22, pp.273-280, 2013. ,
, Miner JH: The glomerular basement membrane, Exp Cell Res, vol.10, pp.973-978, 2012.
Glomerular basement membrane and related glomerular disease, Transl Res, vol.160, pp.291-297, 2012. ,
Glomerular basement membrane composition and the filtration barrier, Pediatr Nephrol, vol.26, pp.1413-1417, 2011. ,
Glomerular heparan sulfate alterations: Mechanisms and relevance for proteinuria, Kidney Int, vol.57, pp.385-400, 2000. ,
N-sulfation of heparan sulfate is critical for syndecan-4-mediated podocyte cell-matrix interactions, Am J Physiol Renal Physiol, vol.310, pp.1123-1135, 2016. ,
The glomerular basement membrane as a model system to study the bioactivity of heparan sulfate glycosaminoglycans, Microsc Microanal, vol.18, pp.3-21, 2012. ,
Podocyte-specific deletion of NDST1, a key enzyme in the sulfation of heparan sulfate glycosaminoglycans, leads to abnormalities in podocyte organization in vivo, Kidney Int, vol.85, pp.307-318, 2014. ,
Podocytes require the engagement of cell surface heparan sulfate proteoglycans for adhesion to extracellular matrices, Kidney Int, vol.78, pp.1088-1099, 2010. ,
The exostosin family: Proteins with many functions, Matrix Biol, vol.35, pp.25-33, 2014. ,
Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1), Nat Genet, vol.11, pp.137-143, 1995. ,
In vitro polymerization of heparan sulfate backbone by the EXT proteins, J Biol Chem, vol.278, pp.41333-41337, 2003. ,
Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation, J Biol Chem, vol.282, pp.32802-32810, 2007. ,
Glomerular filtration: The charge debate charges ahead, Kidney Int, vol.74, pp.259-261, 2008. ,
Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria, Kidney Int, vol.74, pp.289-299, 2008. ,
Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease, Nephrol Dial Transplant, vol.30, pp.1814-1824, 2015. ,
Genetic heterogeneity in families with hereditary multiple exostoses, Am J Hum Genet, vol.53, pp.71-79, 1993. ,